Rectal Cancer Patients Clinical Trials
0 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 2
Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）
Rectal Cancer Patients
The Affiliated Hospital of Qingdao University35 enrolled1 locationNCT06647680
Recruiting
Phase 2
SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC
Rectal CancerRectal AdenocarcinomaTargeted Therapy+6 more
Ruijin Hospital104 enrolled1 locationNCT07198165
Recruiting
Not Applicable
Rectal Cancer CTC Trial
Rectal Cancer Patients
University Hospital Ostrava120 enrolled4 locationsNCT07194616
Recruiting
Phase 2
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.
Rectal Cancer Patients
Sun Yat-sen University88 enrolled1 locationNCT06911684